Skip to content
10-K

Annual Report

Relay Therapeutics, Inc. RLAY

0001193125-26-076739

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 178.73M sh
Capex FY 2025 · Dec 31, 2025 $410K
Capex FY 2025 · Dec 31, 2024 $2.02M
Capex FY 2025 · Dec 31, 2023 $4.13M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$235.46M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$249.11M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$300.32M
Cash And Equivalents FY 2025 · Dec 31, 2025 $84.02M
Cash And Equivalents FY 2025 · Dec 31, 2024 $124.29M
Stockholders Equity FY 2025 · Dec 31, 2025 $567.06M
Stockholders Equity FY 2025 · Dec 31, 2024 $777.79M
Stockholders Equity FY 2025 · Dec 31, 2023 $752M
Stockholders Equity FY 2025 · Dec 31, 2022 $950.22M
Current Liabilities FY 2025 · Dec 31, 2025 $25.58M
Current Liabilities FY 2025 · Dec 31, 2024 $50.73M
Total Liabilities FY 2025 · Dec 31, 2025 $54.27M
Total Liabilities FY 2025 · Dec 31, 2024 $93.5M
Current Assets FY 2025 · Dec 31, 2025 $578.28M
Current Assets FY 2025 · Dec 31, 2024 $809.2M
Total Assets FY 2025 · Dec 31, 2025 $621.33M
Total Assets FY 2025 · Dec 31, 2024 $871.3M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.61
Eps Diluted FY 2025 · Dec 31, 2024 −$2.36
Eps Diluted FY 2025 · Dec 31, 2023 −$2.79
Eps Basic FY 2025 · Dec 31, 2025 −$1.61
Eps Basic FY 2025 · Dec 31, 2024 −$2.36
Eps Basic FY 2025 · Dec 31, 2023 −$2.79
Sga Expense FY 2025 · Dec 31, 2025 $56.71M
Sga Expense FY 2025 · Dec 31, 2024 $76.59M
Sga Expense FY 2025 · Dec 31, 2023 $74.95M
Net Income FY 2025 · Dec 31, 2025 −$276.48M
Net Income FY 2025 · Dec 31, 2024 −$337.71M
Net Income FY 2025 · Dec 31, 2023 −$341.97M
Operating Income FY 2025 · Dec 31, 2025 −$302.74M
Operating Income FY 2025 · Dec 31, 2024 −$372.47M
Operating Income FY 2025 · Dec 31, 2023 −$373M
Revenue FY 2025 · Dec 31, 2025 $15.36M
Revenue FY 2025 · Dec 31, 2024 $10.01M
Revenue FY 2025 · Dec 31, 2023 $25.55M